NYSE:COO - Cooper Companies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cooper Companies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $312.86 +0.77 (+0.25 %) (As of 12/5/2019 04:00 PM ET) Add Compare Today's Range$311.11Now: $312.86▼$314.9450-Day Range$280.97MA: $297.98▼$317.5452-Week Range$228.65Now: $312.86▼$344.32Volume327,300 shsAverage Volume319,514 shsMarket Capitalization$15.51 billionP/E Ratio27.21Dividend Yield0.02%Beta0.91 ProfileAnalyst RatingsAdvanced ChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry Ophthalmic goods Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNYSE:COO Previous Symbol CUSIP21664840 CIK711404 Webhttp://www.coopercos.com/ Phone925-460-3600Debt Debt-to-Equity Ratio0.39 Current Ratio1.29 Quick Ratio0.73Price-To-Earnings Trailing P/E Ratio27.21 Forward P/E Ratio25.39 P/E Growth2.31 Sales & Book Value Annual Sales$2.53 billion Price / Sales6.12 Cash Flow$17.22 per share Price / Cash Flow18.17 Book Value$67.31 per share Price / Book4.65Profitability EPS (Most Recent Fiscal Year)$11.50 Net Income$139.90 million Net Margins17.08% Return on Equity17.15% Return on Assets9.61%Miscellaneous Employees12,000 Outstanding Shares49,574,000Market Cap$15.51 billion Next Earnings Date12/5/2019 (Confirmed) OptionableOptionable Receive COO News and Ratings via Email Sign-up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter. COO Rates by TradingView Cooper Companies (NYSE:COO) Frequently Asked Questions What is Cooper Companies' stock symbol? Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO." How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies? Cooper Companies declared a Semi-Annual dividend on Wednesday, July 10th. Stockholders of record on Tuesday, July 23rd will be paid a dividend of $0.03 per share on Wednesday, August 7th. The ex-dividend date is Monday, July 22nd. View Cooper Companies' Dividend History. How were Cooper Companies' earnings last quarter? Cooper Companies Inc (NYSE:COO) posted its quarterly earnings data on Thursday, August, 30th. The medical device company reported $3.00 EPS for the quarter, missing analysts' consensus estimates of $3.07 by $0.07. The medical device company had revenue of $660 million for the quarter, compared to analyst estimates of $653.44 million. Cooper Companies had a return on equity of 17.15% and a net margin of 17.08%. View Cooper Companies' Earnings History. When is Cooper Companies' next earnings date? Cooper Companies is scheduled to release their next quarterly earnings announcement on Thursday, December 5th 2019. View Earnings Estimates for Cooper Companies. What guidance has Cooper Companies issued on next quarter's earnings? Cooper Companies issued an update on its FY20 earnings guidance on Thursday, December, 5th. The company provided EPS guidance of $12.60-13.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $13.08. The company issued revenue guidance of $2.767-2.817 billion, compared to the consensus revenue estimate of $2.82 billion. What price target have analysts set for COO? 11 brokers have issued 1 year price targets for Cooper Companies' stock. Their forecasts range from $221.00 to $365.00. On average, they expect Cooper Companies' stock price to reach $325.30 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price. View Analyst Price Targets for Cooper Companies. What is the consensus analysts' recommendation for Cooper Companies? 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 1 sell rating, 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cooper Companies. Has Cooper Companies been receiving favorable news coverage? Headlines about COO stock have been trending somewhat positive this week, InfoTrie reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cooper Companies earned a daily sentiment score of 1.3 on InfoTrie's scale. They also gave news articles about the medical device company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Cooper Companies. Are investors shorting Cooper Companies? Cooper Companies saw a decrease in short interest in the month of November. As of November 15th, there was short interest totalling 945,600 shares, a decrease of 7.3% from the October 31st total of 1,020,000 shares. Based on an average trading volume of 307,800 shares, the days-to-cover ratio is currently 3.1 days. Currently, 1.9% of the company's shares are short sold. View Cooper Companies' Current Options Chain. Who are some of Cooper Companies' key competitors? Some companies that are related to Cooper Companies include Align Technology (ALGN), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Anika Therapeutics (ANIK), Antares Pharma (ATRS), Cerus (CERS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO). What other stocks do shareholders of Cooper Companies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cooper Companies investors own include Netflix (NFLX), NVIDIA (NVDA), Starbucks (SBUX), Booking (BKNG), Baidu (BIDU), Boeing (BA), Adobe (ADBE), Alibaba Group (BABA), Align Technology (ALGN) and Intuitive Surgical (ISRG). Who are Cooper Companies' key executives? Cooper Companies' management team includes the folowing people: Mr. Albert G. White III, Pres, CEO & Director (Age 49)Mr. Brian G. Andrews, Sr. VP, CFO & Treasurer (Age 40)Mr. Daniel G. McBride, Exec. VP & COO (Age 55)Ms. Holly R. Sheffield, Exec. VP & Chief Strategy Officer (Age 48)Dr. Robert D. Auerbach, Pres of Coopersurgical Inc (Age 58) Who are Cooper Companies' major shareholders? Cooper Companies' stock is owned by many different of institutional and retail investors. Top institutional investors include State Street Corp (4.20%), Massachusetts Financial Services Co. MA (4.01%), Generation Investment Management LLP (3.08%), Veritas Asset Management LLP (2.00%), California Public Employees Retirement System (0.80%) and WCM Investment Management LLC (0.75%). Company insiders that own Cooper Companies stock include A Thomas Bender, Agostino Ricupati, Allan E Rubenstein, Brian G Andrews, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg. View Institutional Ownership Trends for Cooper Companies. Which major investors are selling Cooper Companies stock? COO stock was sold by a variety of institutional investors in the last quarter, including Generation Investment Management LLP, Findlay Park Partners LLP, Massachusetts Financial Services Co. MA, Public Employees Retirement Association of Colorado, State Street Corp, Sawgrass Asset Management LLC, BB&T Securities LLC and Fisher Asset Management LLC. Company insiders that have sold Cooper Companies company stock in the last year include Agostino Ricupati, Allan E Rubenstein, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg. View Insider Buying and Selling for Cooper Companies. Which major investors are buying Cooper Companies stock? COO stock was purchased by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., California Public Employees Retirement System, State of Alaska Department of Revenue, WCM Investment Management LLC, Squarepoint Ops LLC, State of Tennessee Treasury Department, Russell Investments Group Ltd. and Pictet Asset Management Ltd.. View Insider Buying and Selling for Cooper Companies. How do I buy shares of Cooper Companies? Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Cooper Companies' stock price today? One share of COO stock can currently be purchased for approximately $312.86. How big of a company is Cooper Companies? Cooper Companies has a market capitalization of $15.51 billion and generates $2.53 billion in revenue each year. The medical device company earns $139.90 million in net income (profit) each year or $11.50 on an earnings per share basis. Cooper Companies employs 12,000 workers across the globe.View Additional Information About Cooper Companies. What is Cooper Companies' official website? The official website for Cooper Companies is http://www.coopercos.com/. How can I contact Cooper Companies? Cooper Companies' mailing address is 6140 Stoneridge Mall Road Suite 590, PLEASANTON CA, 94588. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected] MarketBeat Community Rating for Cooper Companies (NYSE COO)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 514 (Vote Outperform)Underperform Votes: 447 (Vote Underperform)Total Votes: 961MarketBeat's community ratings are surveys of what our community members think about Cooper Companies and other stocks. Vote "Outperform" if you believe COO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/5/2019 by MarketBeat.com StaffFeatured Article: Neutral Rating